Age-Related Eye Disease Study (AREDS) Follow-Up

Launched by NATIONAL EYE INSTITUTE (NEI) · Jan 4, 2008

Keywords

ClinConnect Summary

The Age-Related Eye Disease Study (AREDS) Follow-Up is a clinical trial that looks at how age-related eye conditions, specifically age-related macular degeneration (AMD) and cataracts, change over time. This study is for individuals who previously participated in the original AREDS or AREDS2 studies and completed their final follow-up visit. To be eligible, participants must be at least 50 years old and able to come to the National Institutes of Health (NIH) for annual eye exams.

During the study, participants will have a thorough eye exam once a year, which includes tests to check their vision and to look inside the eye using special equipment. They may also have their blood tested for cholesterol levels and genes that can affect inflammation. The trial is currently active but not recruiting new participants. This is an important opportunity to help researchers understand how AMD and cataracts progress, which can lead to better treatments for these common age-related eye diseases.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• Participants will be eligible if they:
• • Were enrolled in the AREDS or AREDS2 protocol and successfully completed the final AREDS or AREDS2 follow-up visit.
• • Can understand and provide informed consent.
• EXCLUSION CRITERIA:
• Participants will not be eligible if they:
• • Are under the age of 50.
• • Are not able to return to NIH for examination for the duration of the trial.
• • Have any systemic diseases that compromise the ability to provide adequate ophthalmologic examination.